ACRS vs BIIB: Which Stock is Better?
Side-by-side comparison of Aclaris Therapeutics Inc and Biogen Inc in 2026
ACRS
Aclaris Therapeutics Inc
$4.43
BIIB
Biogen Inc
$165.38
Key Metrics Comparison
| Metric | ACRS | BIIB | Winner |
|---|---|---|---|
| Market Cap | $283.86M | $24.26B | BIIB |
| P/E Ratio | N/A | 15.09 | BIIB |
| EPS (TTM) | $N/A | $10.96 | BIIB |
| Revenue Growth | -0.2% | 0.0% | BIIB |
| Gross Margin | -275.7% | 76.6% | BIIB |
Analyze ACRS
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACRS or BIIB a better investment?
Comparing ACRS and BIIB: Aclaris Therapeutics Inc has a market cap of $283.86M while Biogen Inc has $24.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACRS and BIIB?
ACRS (Aclaris Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACRS or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACRS or BIIB?
BIIB has higher revenue growth at 0.0% vs -0.2% for ACRS.
Which company is more profitable: ACRS or BIIB?
Biogen Inc (BIIB) has higher gross margins at 76.6% compared to -275.7% for ACRS.
Which is the larger company: ACRS or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $24.26B compared to $283.86M for ACRS.
Should I buy ACRS or BIIB in 2026?
Both ACRS and BIIB have investment merit. ACRS trades at $4.43 while BIIB trades at $165.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACRS and BIIB stock?
Key differences: Market Cap ($283.86M vs $24.26B), P/E Ratio (N/A vs 15.1x), Revenue Growth (-0.2% vs 0.0%), Gross Margin (-275.7% vs 76.6%).